Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
LIVE
BSE
Oct 18, 16:00
2723.80
-2.85 (-0.1%)VOLUME 4,488
LIVE
NSE
Oct 18, 15:55
2724.85
-2.55 (-0.09%) VOLUME 289,279
- Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Dr%20Reddys%20Labs on the go with the moneycontrol app
Yearly Results of Dr Reddys Laboratories |
------------------- in Rs. Cr. ------------------- |
 | ||||||||||
|
||||||||||
| Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 | ||||||
|
||||||||||
| Net Sales/Income from operations | 10,466.70 | 9,302.60 | 9,628.10 | 10,234.80 | 9,927.45 | |||||
| Other Operating Income | 158.80 | 56.70 | 91.70 | 57.10 | 83.49 | |||||
| Total Income From Operations | 10,625.50 | 9,359.30 | 9,719.80 | 10,291.90 | 10,010.94 | |||||
| EXPENDITURE | ||||||||||
| Consumption of Raw Materials | 2,103.20 | 2,011.00 | 1,817.60 | 2,072.70 | 2,322.63 | |||||
| Purchase of Traded Goods | 868.60 | 671.60 | 671.50 | 610.40 | 526.06 | |||||
| Increase/Decrease in Stocks | 66.00 | -51.60 | 1.90 | -28.80 | -28.96 | |||||
| Power & Fuel | -- | -- | -- | -- | -- | |||||
| Employees Cost | 1,931.90 | 1,843.00 | 1,803.30 | 1,693.40 | 1,490.86 | |||||
| Depreciation | 780.60 | 774.10 | 735.10 | 927.50 | 490.23 | |||||
| Excise Duty | -- | -- | -- | -- | -- | |||||
| Admin. And Selling Expenses | -- | -- | 998.50 | 649.50 | 1,063.50 | |||||
| R & D Expenses | -- | -- | -- | -- | -- | |||||
| Provisions And Contingencies | -- | -- | -- | -- | -- | |||||
| Exp. Capitalised | -- | -- | -- | -- | -- | |||||
| Other Expenses | 3,356.10 | 3,555.40 | 2,681.40 | 2,951.40 | 2,245.85 | |||||
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1,519.10 | 555.80 | 1,010.50 | 1,415.80 | 1,900.77 | |||||
| Other Income | 238.40 | 204.00 | 591.20 | 324.90 | 222.85 | |||||
| P/L Before Int., Excpt. Items & Tax | 1,757.50 | 759.80 | 1,601.70 | 1,740.70 | 2,123.62 | |||||
| Interest | 56.80 | 62.80 | 57.20 | 64.10 | 63.80 | |||||
| P/L Before Exceptional Items & Tax | 1,700.70 | 697.00 | 1,544.50 | 1,676.60 | 2,059.82 | |||||
| Exceptional Items | -- | -- | -- | -- | -- | |||||
| P/L Before Tax | 1,700.70 | 697.00 | 1,544.50 | 1,676.60 | 2,059.82 | |||||
| Tax | 423.40 | 130.10 | 160.40 | 302.30 | 380.47 | |||||
| P/L After Tax from Ordinary Activities | 1,277.30 | 566.90 | 1,384.10 | 1,374.30 | 1,679.35 | |||||
| Prior Year Adjustments | -- | -- | -- | -- | -- | |||||
| Extra Ordinary Items | -- | -- | -- | -- | -- | |||||
| Net Profit/(Loss) For the Period | 1,277.30 | 566.90 | 1,384.10 | 1,374.30 | 1,679.35 | |||||
| Equity Share Capital | 83.00 | 83.00 | 82.90 | 85.30 | 85.20 | |||||
| Reserves Excluding Revaluation Reserves | 12,601.10 | 11,724.80 | 11,517.70 | 11,520.10 | 10,548.80 | |||||
| Equity Dividend Rate (%) | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 | |||||
| EPS Before Extra Ordinary | ||||||||||
| Basic EPS | 76.98 | 34.19 | 83.05 | 80.59 | 98.60 | |||||
| Diluted EPS | 76.85 | 34.12 | 82.88 | 80.34 | 98.18 | |||||
| EPS After Extra Ordinary | ||||||||||
| Basic EPS | 76.98 | 34.19 | 83.05 | 80.59 | 98.60 | |||||
| Diluted EPS | 76.85 | 34.12 | 82.88 | 80.34 | 98.18 | |||||
| Public Share Holding | ||||||||||
| No Of Shares (Crores) | -- | -- | -- | -- | 9.82 | |||||
| Share Holding (%) | -- | -- | -- | -- | 57.63 | |||||
| Promoters and Promoter Group Shareholding | ||||||||||
| a) Pledged/Encumbered | ||||||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |||||
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |||||
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |||||
| b) Non-encumbered | ||||||||||
| - Number of shares (Crores) | -- | -- | -- | -- | 4.34 | |||||
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | 100.00 | |||||
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | 25.48 | |||||
| Notes |  |
|||||||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of Dr Reddys Labs
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
No news.
Quick Links for drreddyslaboratories
Related Searches
drreddyslaboratories Stock Price, Dr%20Reddys%20Labs Stock Quote, Dr%20Reddys%20Labs Results , Dr%20Reddys%20Labs News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2019 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Chennai | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.